Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Deferred Taxes (2016 - 2017)

Historic Deferred Taxes for Lisata Therapeutics (LSTA) over the last 8 years, with Q1 2017 value amounting to -$49531.0.

  • Lisata Therapeutics' Deferred Taxes rose 720.71% to -$49531.0 in Q1 2017 from the same period last year, while for Mar 2017 it was $3847.0, marking a year-over-year decrease of 9997.77%. This contributed to the annual value of $11.5 million for FY2017, which is N/A changed from last year.
  • According to the latest figures from Q1 2017, Lisata Therapeutics' Deferred Taxes is -$49531.0, which was up 720.71% from $147286.0 recorded in Q4 2016.
  • Over the past 5 years, Lisata Therapeutics' Deferred Taxes peaked at $13.6 million during Q4 2015, and registered a low of -$447568.0 during Q2 2013.
  • For the 5-year period, Lisata Therapeutics' Deferred Taxes averaged around $1.1 million, with its median value being -$46793.5 (2015).
  • Its Deferred Taxes has fluctuated over the past 5 years, first tumbled by 26394.58% in 2013, then soared by 791514.55% in 2015.
  • Over the past 5 years, Lisata Therapeutics' Deferred Taxes (Quarter) stood at -$287779.0 in 2013, then skyrocketed by 185.62% to $246385.0 in 2014, then surged by 5433.39% to $13.6 million in 2015, then plummeted by 98.92% to $147286.0 in 2016, then plummeted by 133.63% to -$49531.0 in 2017.
  • Its Deferred Taxes was -$49531.0 in Q1 2017, compared to $147286.0 in Q4 2016 and -$46954.0 in Q3 2016.